TITLE

Long-term effects of cardiac resynchronisation therapy in patients with atrial fibrillation

AUTHOR(S)
Khadjooi, K.; Foley, P. W.; Chalil, S.; Anthony, J.; Smith, A. E. A.; Frenneaux, M. P.; Leyva, F.
PUB. DATE
July 2008
SOURCE
Heart;Jul2008, Vol. 94 Issue 7, p879
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objective: To compare the effects of cardiac resynchronisation therapy (CAT) in patients with heart failure (HF) in either atrial fibrillation (AF) or sinus rhythm (SR). Design: Prospective observational study. Patients: 295 consecutive patients with HF (permanent AF in 66, paroxysmal AF in 20, SR in 209; New York Heart Association (NYHA) class Ill or IV; left ventricular ejection fraction (LVEF) ⩽35%, QRS ⩾120 ms). Interventions: All patients underwent CRT without atrioventricular junction ablation. Main outcome measures: The primary end point was the composite of cardiovascular death or unplanned hospitalisation for major cardiovascular events. Secondary end points included the composite of cardiovascular death or hospitalisation for worsening HF. Cardiovascular mortality, total mortality and changes in NYHA class, 6-minute walking distance, quality of life (Minnesota Living with Heart Failure questionnaire) and echocardiographic variables were also considered. Results: Over a follow-up period of up to 6.8 years, no differences emerged between patients in AF or SR in any of the mortality or morbidity end points. The AF and SR groups derived similar improvements in mean NYHA class (-1.3 vs -1.2), 6-minute walking distance (92.3 vs 78.4 m) and quality of life scores (-25.2 vs -18.7) (all p<0.001). In both the AF and the SR groups, reductions were seen in left ventricular end-systolic (-25.9 vs -34.5 ml, both p<0.001) and end-diastolic (-20.2 ml, p = 0.001 vs 26.2 ml, p<0.001) volumes and improvements in LVEF (4.69% vs 7.86%, both p<0.001). Conclusions: Cardiac resynchronisation therapy leads to similar prognostic and symptomatic benefits in patients in AF and SR, even without atrioventricular junction ablation. Echocardiographic improvements are also comparable.
ACCESSION #
32900178

 

Related Articles

  • New Concepts for Management of Atrial Fibrillation. Rizzo, Toni; Fauchier, Laurent; Rincón, Luis M.; Steinberg, Benjamin A.; Camm, John; Brachmann, Johannes // MD Conference Express;Aug2015, Vol. 15 Issue 22, p14 

    Recent large registry studies of patients with AF have found an increased use of oral anticoagulation for prevention of thromboembolic events, consistent with the most recent Professional Guidelines. Although AF management has improved in clinical practice, anticoagulation use is often...

  • Cardiac resynchronisation therapy in chronic atrial fibrillation: impact on left atrial size and reversal to sinus rhythm. Kiès, P.; Leclercq, C.; Bleeker, G. B.; Crocq, C.; Molhoek, S. G.; Poulain, C.; van Erven, L.; Bootsma, M.; Zeppenfeld, K.; van der Wall, E. E.; Daubert, J.-C.; Schalij, M. J.; Bax, J. J. // Heart;Apr2006, Vol. 92 Issue 4, p490 

    Objective: To evaluate the impact of long term cardiac resynchronisation therapy (CRT) on left atrial and left ventricular (LV) reverse remodelling and reversal to sinus rhythm (SR) in patients with heart failure with atrial fibrillation (AF). Patients: 74 consecutive patients (age 68 (8) years;...

  • World Atrial Fibrillation Awareness Day - It's About Time! Lakkireddy, Dhanunjaya // JAFIB: Journal of Atrial Fibrillation; 

    The author reflects on the prevalence of Atrial Fibrillation (AF) which have increased and relatively not common before the age of 60 years affecting 10% of population in the U.S. He states that coronary artery disease happens due to functional stenosis or mechanical obstruction of coronary...

  • Mortality Risk Associated with AF in Myocardial Infarction Patients. Sankaranarayanan, Rajiv // JAFIB: Journal of Atrial Fibrillation; 

    Atrial fibrillation (AF) complicating myocardial infarction (MI) has been a controversial topic for the last few decades. It has generated a plethora of debates regarding whether it is a risk indicator of comorbidities and poor haemodynamic status or independent causal mediator of poor outcomes....

  • Heart Failure Complicated by Atrial Fibrillation: Rate or Rhythm Control? Kuritzky, Louis // Primary Care Reports;Sep2008 Clinical Briefs in Primary, Vol. 13 Issue 9, p18 

    The article discusses research being done on the use of rate and rhythm control in treating patients with heart failure (HF) and atrial fibrillation (AFIB). It references a study by D. Roy et al, which appeared in the 2008 issue of "New England Journal of Medicine." The researchers recommended...

  • Atrial Fibrillation Following Investigation of Rhythm Management: AFFIRM Trial Outcomes. What Might Be Their Implications for Arrhythmia Control?  // Journal of Cardiovascular Pharmacology & Therapeutics;Jul2002, Vol. 7 Issue 3, p131 

    This article focuses on atrial fibrillation following investigation of rhythm management. During the last decade or so, major changes have been made in the approaches to the control of supraventricular as well as ventricular tachyarrhythmias. Atrial fibrillation is the most common cardiac...

  • A Review of Carvedilol Arrhythmia Data in Clinical Trials. Kowey, Peter R. // Journal of Cardiovascular Pharmacology & Therapeutics;Jun2005 Supplement, Vol. 10 Issue 2S, pS59 

    The article reports that β-blockers have been conclusively shown to reduce all-cause mortality in heart failure patients and are now being studied more intensively to define their role in clinical use as antiarrhythmic agents. Atrial fibrillation (AF) is a common arrhythmia in heart failure...

  • Fibrilatia atriala si supravietuirea la pacientii cu insuficienta cardiaca cu fractie de ejectie scazuta. Macarie, Ileana Tepes Piser; Macarie, C. // Romanian Journal of Cardiology;Mar2012, Vol. 22 Issue 1, p4 

    Atrial fibrillation (AF) is the most common arrhythmia in patients with heart failure (HF); despite its negative hemodynamic consequences, the prognostic influence of AF in patients with HF remains controversial. Th e aims of the paper - To evaluate the atrial fibrillation prevalence in a...

  • Rhythm control and rate control did not differ for CV mortality in atrial fibrillation and congestive heart failure. Cairns, John // ACP Journal Club;10/21/2008, Vol. 149 Issue 4, p6 

    The article focuses on a study that compared rhythm control with rate control for reducing cardiovascular (CV) mortality in patients with atrial fibrillation (AF) and congestive heart failure (CHF). The study was conducted by researchers D. Roy, M. Talajic and S. Nattel. Rate-control therapy...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics